INS and Hypoglycemia: Bellido et al. in a prospective, open-label randomized trial, comparing an intermediate-acting insulin (NPH) regular insulin 70/30 mixture with a basal-bolus regimen in hospitalized patients found comparable glycemic outcomes but a significantly higher incidence of hypoglycemia in the group receiving the insulin mixture.